Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.
[Research progresses of monoclonal antibodies therapy in neuromyelitis optica].
A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod.
Direct effects of secretory products of immune cells on neurons and glia.
A new model for primary-progressive multiple sclerosis?
The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.
Neuroimaging of dementia.
Off-pump coronary surgery in a patient with multiple sclerosis.
[Diet and multiple sclerosis].
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis.
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network.
Treatment Adherence and Transitioning Youth in Pediatric Multiple Sclerosis.
The most fulminant course of the Marburg variant of multiple sclerosis-autopsy findings.
The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue.
Strategies for regeneration of components of nervous system: scaffolds, cells and biomolecules.
Cecal Ligation and Puncture Results in Long-Term Central Nervous System Myeloid Inflammation.
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort.
Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions.
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
Future MRI tools in multiple sclerosis.
Multi-slice myelin water imaging for practical clinical applications at 3.0 T.
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.

Pages